Karin Lori Andersson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis B, Chronic | 3 | 2016 | 410 | 0.420 |
Why?
|
| Adenoma | 1 | 2021 | 2159 | 0.350 |
Why?
|
| Hepatitis A | 1 | 2010 | 127 | 0.350 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2008 | 219 | 0.270 |
Why?
|
| Antiviral Agents | 2 | 2009 | 3048 | 0.240 |
Why?
|
| Travel | 1 | 2010 | 796 | 0.240 |
Why?
|
| Drug Monitoring | 1 | 2009 | 961 | 0.210 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 6919 | 0.190 |
Why?
|
| Fibrosis | 1 | 2008 | 2051 | 0.190 |
Why?
|
| Vascular Fistula | 1 | 2019 | 50 | 0.160 |
Why?
|
| Liver Function Tests | 1 | 2020 | 525 | 0.160 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 124 | 0.150 |
Why?
|
| Intestinal Fistula | 1 | 2019 | 142 | 0.150 |
Why?
|
| Iliac Artery | 1 | 2019 | 343 | 0.140 |
Why?
|
| Hepatitis C | 1 | 2006 | 1579 | 0.130 |
Why?
|
| Colonoscopy | 2 | 2021 | 1395 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 2293 | 0.130 |
Why?
|
| Foreign Bodies | 1 | 2019 | 402 | 0.120 |
Why?
|
| Abdominal Pain | 1 | 2019 | 1067 | 0.100 |
Why?
|
| Postnatal Care | 1 | 2014 | 260 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2020 | 1301 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2019 | 1116 | 0.100 |
Why?
|
| Aftercare | 1 | 2016 | 913 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2020 | 3608 | 0.080 |
Why?
|
| Postpartum Period | 1 | 2016 | 1178 | 0.080 |
Why?
|
| Sex Factors | 1 | 2021 | 10553 | 0.070 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3198 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2012 | 746 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2016 | 2150 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2012 | 789 | 0.060 |
Why?
|
| Liver | 1 | 2020 | 7514 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 2380 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 3200 | 0.040 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 1999 | 25 | 0.040 |
Why?
|
| HIV Infections | 1 | 2006 | 17347 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4851 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1999 | 456 | 0.040 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 249 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1589 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2019 | 249 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1999 | 403 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6304 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 534 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5493 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2008 | 3239 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2016 | 294 | 0.030 |
Why?
|
| Humans | 10 | 2021 | 761208 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2008 | 6224 | 0.030 |
Why?
|
| Observer Variation | 1 | 2020 | 2610 | 0.030 |
Why?
|
| Angiography | 1 | 2019 | 1597 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1603 | 0.030 |
Why?
|
| Massachusetts | 2 | 2016 | 8837 | 0.030 |
Why?
|
| Incidence | 1 | 2010 | 21365 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12052 | 0.020 |
Why?
|
| United States | 2 | 2010 | 72339 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13249 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2444 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3134 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12976 | 0.020 |
Why?
|
| Female | 5 | 2021 | 392544 | 0.020 |
Why?
|
| Male | 4 | 2021 | 360693 | 0.020 |
Why?
|
| Risk Factors | 2 | 2020 | 74239 | 0.020 |
Why?
|
| Gastroenterology | 1 | 2014 | 580 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 13367 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 3885 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1999 | 4935 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 4014 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 1986 | 192 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 1986 | 248 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2756 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15308 | 0.010 |
Why?
|
| Pregnancy | 2 | 2016 | 29893 | 0.010 |
Why?
|
| Middle Aged | 3 | 2020 | 220853 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 58952 | 0.010 |
Why?
|
| Epinephrine | 1 | 1986 | 791 | 0.010 |
Why?
|
| Adult | 4 | 2020 | 221119 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7966 | 0.010 |
Why?
|
| Catenins | 1 | 1999 | 44 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29687 | 0.010 |
Why?
|
| Aged | 2 | 2012 | 169288 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18384 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7400 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 812 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1986 | 836 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2014 | 4678 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2016 | 80674 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20588 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1999 | 2468 | 0.010 |
Why?
|
| Plasmids | 1 | 1999 | 2261 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 1593 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 41496 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39126 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 88298 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 59221 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 54435 | 0.000 |
Why?
|
| Rats, Inbred WKY | 1 | 1986 | 150 | 0.000 |
Why?
|
| Cell Line | 1 | 1999 | 15545 | 0.000 |
Why?
|
| Macrophages | 1 | 1999 | 5753 | 0.000 |
Why?
|
| Synaptic Transmission | 1 | 1986 | 1167 | 0.000 |
Why?
|
| Time Factors | 1 | 1999 | 39957 | 0.000 |
Why?
|
| Rats | 1 | 1986 | 23704 | 0.000 |
Why?
|
| Animals | 1 | 1986 | 168079 | 0.000 |
Why?
|